Annual Working Capital
$348.09 M
+$203.00 M+139.91%
31 December 2023
Summary:
Viking Therapeutics annual working capital is currently $348.09 million, with the most recent change of +$203.00 million (+139.91%) on 31 December 2023. During the last 3 years, it has risen by +$104.11 million (+42.67%). VKTX annual working capital is now at all-time high.VKTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$910.96 M
-$9.67 M-1.05%
30 September 2024
Summary:
Viking Therapeutics quarterly working capital is currently $910.96 million, with the most recent change of -$9.67 million (-1.05%) on 30 September 2024. Over the past year, it has increased by +$543.07 million (+147.62%). VKTX quarterly working capital is now -2.42% below its all-time high of $933.56 million, reached on 31 March 2024.VKTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VKTX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +139.9% | +147.6% |
| 3 y3 years | +42.7% | +327.8% |
| 5 y5 years | +17.0% | +221.8% |
VKTX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +139.9% | -2.4% | +580.7% |
| 5 y | 5 years | at high | +139.9% | -2.4% | +580.7% |
| alltime | all time | at high | +1700.9% | -2.4% | +3431.0% |
Viking Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $910.96 M(-1.1%) |
| June 2024 | - | $920.63 M(-1.4%) |
| Mar 2024 | - | $933.56 M(+168.2%) |
| Dec 2023 | $348.09 M(+139.9%) | $348.09 M(-5.4%) |
| Sept 2023 | - | $367.89 M(-4.7%) |
| June 2023 | - | $385.89 M(+188.4%) |
| Mar 2023 | - | $133.82 M(-7.8%) |
| Dec 2022 | $145.09 M(-28.1%) | $145.09 M(-4.0%) |
| Sept 2022 | - | $151.09 M(-8.4%) |
| June 2022 | - | $165.00 M(-9.4%) |
| Mar 2022 | - | $182.03 M(-9.8%) |
| Dec 2021 | $201.75 M(-17.3%) | $201.75 M(-5.3%) |
| Sept 2021 | - | $212.93 M(-5.3%) |
| June 2021 | - | $224.79 M(-5.1%) |
| Mar 2021 | - | $236.95 M(-2.9%) |
| Dec 2020 | $243.97 M(-11.8%) | $243.97 M(-3.7%) |
| Sept 2020 | - | $253.42 M(-3.1%) |
| June 2020 | - | $261.56 M(-2.4%) |
| Mar 2020 | - | $267.90 M(-3.2%) |
| Dec 2019 | $276.72 M | $276.72 M(-2.2%) |
| Sept 2019 | - | $283.06 M(-1.7%) |
| June 2019 | - | $288.02 M(-2.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $294.22 M(-1.1%) |
| Dec 2018 | $297.58 M(+2155.4%) | $297.58 M(-1.4%) |
| Sept 2018 | - | $301.87 M(+115.4%) |
| June 2018 | - | $140.15 M(+93.6%) |
| Mar 2018 | - | $72.39 M(+448.7%) |
| Dec 2017 | $13.19 M(+76.0%) | $13.19 M(+590.2%) |
| Sept 2017 | - | $1.91 M(-70.8%) |
| June 2017 | - | $6.54 M(-42.1%) |
| Mar 2017 | - | $11.29 M(+50.6%) |
| Dec 2016 | $7.50 M(-43.3%) | $7.50 M(-21.4%) |
| Sept 2016 | - | $9.55 M(-24.1%) |
| June 2016 | - | $12.57 M(+22.7%) |
| Mar 2016 | - | $10.24 M(-22.5%) |
| Dec 2015 | $13.22 M(-160.8%) | $13.22 M(+0.1%) |
| Sept 2015 | - | $13.21 M(-24.1%) |
| June 2015 | - | $17.39 M(-163.6%) |
| Mar 2015 | - | -$27.35 M(+25.8%) |
| Dec 2014 | -$21.74 M(<-9900.0%) | -$21.74 M(-5.7%) |
| June 2014 | - | -$23.05 M(+6485.4%) |
| Mar 2014 | - | -$350.00 K |
| Dec 2013 | $52.10 K(-195.8%) | - |
| Dec 2012 | -$54.40 K | - |
FAQ
- What is Viking Therapeutics annual working capital?
- What is the all time high annual working capital for Viking Therapeutics?
- What is Viking Therapeutics annual working capital year-on-year change?
- What is Viking Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Viking Therapeutics?
- What is Viking Therapeutics quarterly working capital year-on-year change?
What is Viking Therapeutics annual working capital?
The current annual working capital of VKTX is $348.09 M
What is the all time high annual working capital for Viking Therapeutics?
Viking Therapeutics all-time high annual working capital is $348.09 M
What is Viking Therapeutics annual working capital year-on-year change?
Over the past year, VKTX annual working capital has changed by +$203.00 M (+139.91%)
What is Viking Therapeutics quarterly working capital?
The current quarterly working capital of VKTX is $910.96 M
What is the all time high quarterly working capital for Viking Therapeutics?
Viking Therapeutics all-time high quarterly working capital is $933.56 M
What is Viking Therapeutics quarterly working capital year-on-year change?
Over the past year, VKTX quarterly working capital has changed by +$543.07 M (+147.62%)